Momenta Pharmaceuticals CEO Craig Wheeler's 2018 pay slips 4% to $4.6M
Momenta Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 26, 2019
Momenta Pharmaceuticals reported fiscal year 2018 executive compensation information on April 26, 2019.
In 2018, six executives at Momenta Pharmaceuticals received on average a compensation package of $2.4M, a 17% increase compared to previous year.
Average pay of disclosed executives at Momenta Pharmaceuticals
Craig A. Wheeler, Chief Executive Officer, received $4.6M in total, which decreased by 4% compared to 2017. 35% of Wheeler's compensation, or $1.6M, was in stock awards. Wheeler also received $630K in non-equity incentive plan, $1.6M in option awards, $750K in salary, as well as $30K in other compensation.
For fiscal year 2018, the median employee pay was $175,536 at Momenta Pharmaceuticals. Therefore, the ratio of Craig A. Wheeler's pay to the median employee pay was 26 to one.
Young Kwon, Chief Business Officer, received a compensation package of $2.4M. 74% of the compensation package, or $1.7M, was in stock awards.
Santiago Arroyo, Chief Medical Officer, earned $2.3M in 2018, a 1% decrease compared to previous year.
Anthony Manning, Chief Scientific Officer, received $2.2M in 2018.
Scott M. Storer, Chief Financial Officer, earned $2M in 2018, a 249% increase compared to previous year.
Michelle Robertson, Chief Financial Officer, received $1.2M in 2018.
Related executives
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
Michelle Robertson
Momenta Pharmaceuticals
Chief Financial Officer
Scott Storer
Momenta Pharmaceuticals
Chief Financial Officer
Santiago Arroyo
Momenta Pharmaceuticals
Chief Medical Officer
Young Kwon
Momenta Pharmaceuticals
Chief Business Officer
Anthony Manning
Momenta Pharmaceuticals
Chief Scientific Officer
You may also like
Source: SEC filing on April 26, 2019.